Article Versions Notes

Ehrentraut SF, Muenster S, Kreyer S, Theuerkauf NU, Bode C, Steinhagen F, Ehrentraut H, Schewe J-C, Weber M, Putensen C, et al. Extensive Therapeutic Drug Monitoring of Colistin in Critically Ill Patients Reveals Undetected Risks. Microorganisms. 2020; 8(3):415. https://doi.org/10.3390/microorganisms8030415

Ehrentraut, Stefan Felix, Stefan Muenster, Stefan Kreyer, Nils Ulrich Theuerkauf, Christian Bode, Folkert Steinhagen, Heidi Ehrentraut, Jens-Christian Schewe, Matthias Weber, Christian Putensen, and et al. 2020. "Extensive Therapeutic Drug Monitoring of Colistin in Critically Ill Patients Reveals Undetected Risks" Microorganisms 8, no. 3: 415. https://doi.org/10.3390/microorganisms8030415

Ehrentraut, S. F., Muenster, S., Kreyer, S., Theuerkauf, N. U., Bode, C., Steinhagen, F., Ehrentraut, H., Schewe, J.-C., Weber, M., Putensen, C., & Muders, T. (2020). Extensive Therapeutic Drug Monitoring of Colistin in Critically Ill Patients Reveals Undetected Risks. Microorganisms, 8(3), 415. https://doi.org/10.3390/microorganisms8030415